CBT Augmentation of SSRI Treatment for Geriatric GAD.

Trial Profile

CBT Augmentation of SSRI Treatment for Geriatric GAD.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 May 2013 Primary endpoint 'Penn-State-Worry-Questionnaire' has been met according to results published in the American Journal of Psychiatry.
    • 01 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Aug 2011 Planned end date changed from 1 Jul 2010 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top